Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1991 1
1992 1
1993 1
1994 2
1996 1
1997 1
1998 2
2008 2
2011 2
2012 2
2013 2
2014 3
2015 4
2016 1
2017 1
2018 4
2019 5
2020 7
2021 4
2022 6
2023 3
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study.
Lee CH, Shah AY, Rasco D, Rao A, Taylor MH, Di Simone C, Hsieh JJ, Pinto A, Shaffer DR, Girones Sarrio R, Cohn AL, Vogelzang NJ, Bilen MA, Gunnestad Ribe S, Goksel M, Tennøe ØK, Richards D, Sweis RF, Courtright J, Heinrich D, Jain S, Wu J, Schmidt EV, Perini RF, Kubiak P, Okpara CE, Smith AD, Motzer RJ. Lee CH, et al. Among authors: kubiak p. Lancet Oncol. 2021 Jul;22(7):946-958. doi: 10.1016/S1470-2045(21)00241-2. Epub 2021 Jun 15. Lancet Oncol. 2021. PMID: 34143969 Free PMC article. Clinical Trial.
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Lee CH, Yogesh Shah A, Rao A, Taylor MH, Di Simone C, Hsieh JJ, Pinto A, Gironés Sarrió R, Lee Cohn A, Asim Bilen M, Gunnestad Ribe S, Krohn Tennøe Ø, Richards D, Sweis RF, Courtright J, Heinrich D, Perini R, Kubiak P, Bock D, Okpara CE, Motzer RJ. Lee CH, et al. Among authors: kubiak p. Eur Urol. 2024 Nov;86(5):470-473. doi: 10.1016/j.eururo.2024.05.003. Epub 2024 May 21. Eur Urol. 2024. PMID: 38777648 No abstract available.
Role of the locus coeruleus in emotional activation.
Aston-Jones G, Rajkowski J, Kubiak P, Valentino RJ, Shipley MT. Aston-Jones G, et al. Among authors: kubiak p. Prog Brain Res. 1996;107:379-402. doi: 10.1016/s0079-6123(08)61877-4. Prog Brain Res. 1996. PMID: 8782532 Review. No abstract available.
Design of New Concept of Knitted Hernia Implant.
Żywicka B, Struszczyk MH, Paluch D, Kostanek K, Krucińska I, Kowalski K, Kopias K, Rybak Z, Szymonowicz M, Gutowska A, Kubiak P. Żywicka B, et al. Among authors: kubiak p. Materials (Basel). 2022 Apr 5;15(7):2671. doi: 10.3390/ma15072671. Materials (Basel). 2022. PMID: 35408005 Free PMC article.
Yarrowia lipolytica: the novel and promising 2-phenylethanol producer.
Celińska E, Kubiak P, Białas W, Dziadas M, Grajek W. Celińska E, et al. Among authors: kubiak p. J Ind Microbiol Biotechnol. 2013 Apr;40(3-4):389-92. doi: 10.1007/s10295-013-1240-3. Epub 2013 Feb 27. J Ind Microbiol Biotechnol. 2013. PMID: 23443834 Free PMC article.
Multi-Criterial Analysis Tool to Design a Hybrid Ballistic Plate.
Struszczyk MH, Dmowska-Jasek P, Kubiak P, Łandwijt M, Fejdyś M. Struszczyk MH, et al. Among authors: kubiak p. Materials (Basel). 2021 Jul 20;14(14):4058. doi: 10.3390/ma14144058. Materials (Basel). 2021. PMID: 34300976 Free PMC article.
Efficacy and safety of percutaneous epiphysiodesis.
Inan M, Chan G, Littleton AG, Kubiak P, Bowen JR. Inan M, et al. Among authors: kubiak p. J Pediatr Orthop. 2008 Sep;28(6):648-51. doi: 10.1097/BPO.0b013e3181832475. J Pediatr Orthop. 2008. PMID: 18724201
55 results